Journals / Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi / 2016 / Cilt: 11 - Sayı: 3

The Comparison of the Effects of the Cilostazol on the Stiffness Parameters in Different Arterial Systems in the Patients with Peripheral Arterial Disease

Pages
11–16
Publication Date
2017-03-24
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Pulsatility index, resistive index, systolic/diastolic velocity ratio, intima-media thickness and elastic modulus values were decreased while cross-sectionalcompliance, cross-sectional distensibility and diastolic wall stress valueswere increased with treatment in carotid, femoral and brachial arteries.Carotid, femoral and brachial arteries have similar rates of change.Conclusion: Cilostazol treatment reduced the progression of atherosclerosis without increasing the risk of bleeding in patients with peripheral arterial disease during a long-term follow-up

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Object of this study is to determine the effect of cilostazol onarterial compliance, distensibilty and vascular stiffness in carotid, femoral and brachial arteries through non-invasive methods in patients withstable IC/PAD.Material and Methods: Twenty-nine patients (22 male, 7 female) whohad been treated with cilostazol 100 mg twice daily during six monthwere included in the study.
📊
Key Findings & Data:Ultrasound measurements of carotid, femoral and brachial arteries were performed at baseline, at 3 and 6 monthsafer starting of treatment and the evaluation of the arterial stiffnessmeasurements were performed by the pre-defned method.Results: Te mean age of the participants was 64 years.
💡
Conclusion & Impact:Pulsatility index, resistive index, systolic/diastolic velocity ratio, intima-media thickness and elastic modulus values were decreased while cross-sectionalcompliance, cross-sectional distensibility and diastolic wall stress valueswere increased with treatment in carotid, femoral and brachial arteries.Carotid, femoral and brachial arteries have similar rates of change.Conclusion: Cilostazol treatment reduced the progression of atherosclerosis without increasing the risk of bleeding in patients with peripheral arterial disease during a long-term follow-up
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Peripheral arterial disease · stiffness · Cilostazol

Özet

Objective: Object of this study is to determine the effect of cilostazol onarterial compliance, distensibilty and vascular stiffness in carotid, femoral and brachial arteries through non-invasive methods in patients withstable IC/PAD.Material and Methods: Twenty-nine patients (22 male, 7 female) whohad been treated with cilostazol 100 mg twice daily during six monthwere included in the study. Ultrasound measurements of carotid, femoral and brachial arteries were performed at baseline, at 3 and 6 monthsafer starting of treatment and the evaluation of the arterial stiffnessmeasurements were performed by the pre-defned method.Results: Te mean age of the participants was 64 years. Pulsatility index, resistive index, systolic/diastolic velocity ratio, intima-media thickness and elastic modulus values were decreased while cross-sectionalcompliance, cross-sectional distensibility and diastolic wall stress valueswere increased with treatment in carotid, femoral and brachial arteries.Carotid, femoral and brachial arteries have similar rates of change.Conclusion: Cilostazol treatment reduced the progression of atherosclerosis without increasing the risk of bleeding in patients with peripheral arterial disease during a long-term follow-up

🔖

Cite This Article

BAYKARA, M., SEÇEN, Ö. G. (2017). The Comparison of the Effects of the Cilostazol on the Stiffness Parameters in Different Arterial Systems in the Patients with Peripheral Arterial Disease. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi, Cilt: 11 - Sayı: 3, 11–16. https://ajindex.com/articles/783403

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Robless P, Mikhailidis DP, Stansby GP. Cilostazol